NASDAQ:WBA - Walgreens Boots Alliance Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $43.27
  • Forecasted Upside: 13.74 %
  • Number of Analysts: 16
  • Breakdown:
  • 2 Sell Ratings
  • 14 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$38.04
▲ +0.53 (1.41%)
1 month | 3 months | 12 months
Get New Walgreens Boots Alliance Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WBA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WBA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$43.27
▲ +13.74% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $43.27, with a high forecast of $61.00 and a low forecast of $33.00. The average price target represents a 13.74% upside from the last price of $38.04.
Hold
The current consensus among 16 investment analysts is to hold stock in Walgreens Boots Alliance.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 16 hold ratings
  • 2 sell ratings
5/2/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 14 hold ratings
  • 2 sell ratings
7/31/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 16 hold ratings
  • 2 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 16 hold ratings
  • 1 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 13 hold ratings
  • 1 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 14 hold ratings
  • 1 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 14 hold ratings
  • 1 sell ratings
9/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 14 hold ratings
  • 2 sell ratings
10/23/2020

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 14 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/16/2020CitigroupLower Price TargetNeutral$43.00 ➝ $40.00Low
i
10/8/2020BarclaysLower Price TargetEqual Weight$45.00 ➝ $40.00Medium
i
10/7/2020Bank of AmericaReiterated RatingSell$37.00Medium
i
Rating by Michael Cherny at Bank of America Co.
10/6/2020Goldman Sachs GroupLower Price TargetSell$37.00 ➝ $33.00Medium
i
9/11/2020MizuhoLower Price TargetNeutral$43.00 ➝ $37.00Low
i
9/7/2020Raymond JamesReiterated RatingHoldMedium
i
9/3/2020Morgan StanleyLower Price TargetEqual Weight$45.00 ➝ $40.00Low
i
9/2/2020Royal Bank of CanadaLower Price TargetSector Perform$45.00 ➝ $38.00Low
i
8/27/2020Credit Suisse GroupLower Price TargetNeutral$45.00 ➝ $42.00Medium
i
Rating by A.J. Rice at Credit Suisse Group AG
7/21/2020MizuhoLower Price TargetNeutral$48.00 ➝ $43.00Medium
i
7/10/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$43.00 ➝ $38.00Medium
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
7/10/2020Bank of AmericaLower Price TargetUnderperform$43.00 ➝ $40.00Medium
i
7/10/2020SunTrust BanksLower Price TargetHold$42.00 ➝ $40.00High
i
7/10/2020Royal Bank of CanadaLower Price TargetSector Perform$48.00 ➝ $45.00High
i
7/10/2020Credit Suisse GroupInitiated CoverageHold$50.00 ➝ $45.00High
i
7/10/2020BarclaysLower Price TargetEqual Weight$50.00 ➝ $45.00High
i
7/10/2020CitigroupLower Price TargetNeutral$48.00 ➝ $43.00High
i
7/2/2020Morgan StanleyLower Price TargetEqual Weight$49.00 ➝ $45.00High
i
6/4/2020MizuhoLower Price TargetOutperform ➝ Neutral$53.00 ➝ $48.00Medium
i
Rating by Ann Hynes at Mizuho
5/19/2020CowenLower Price TargetNeutral ➝ Market Perform$54.00 ➝ $48.00Low
i
4/6/2020UBS GroupUpgradeSell ➝ Neutral$49.00 ➝ $44.00High
i
4/3/2020JPMorgan Chase & Co.Lower Price TargetNeutral$62.00 ➝ $56.00Medium
i
4/3/2020SunTrust BanksLower Price TargetPositive ➝ Hold$58.00 ➝ $42.00Low
i
4/3/2020Credit Suisse GroupLower Price TargetNeutral$60.00 ➝ $50.00Low
i
4/3/2020Royal Bank of CanadaLower Price TargetSector Perform$57.00 ➝ $48.00Medium
i
4/3/2020BarclaysLower Price TargetEqual Weight$60.00 ➝ $50.00Medium
i
4/3/2020Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$51.00 ➝ $43.00Low
i
4/2/2020Wells Fargo & CompanyReiterated RatingHoldLow
i
Rating by Peter Costa at Wells Fargo & Company
4/1/2020Credit Suisse GroupLower Price TargetNeutral$60.00 ➝ $50.00High
i
2/10/2020CowenLower Price TargetMarket Perform$60.00 ➝ $54.00Low
i
1/9/2020MizuhoReiterated RatingHold$59.00Low
i
Rating by Ann Hynes at Mizuho
1/2/2020Bank of AmericaReiterated RatingSell$50.00Low
i
Rating by Michael Cherny at Bank of America Co.
12/18/2019SunTrust BanksBoost Price TargetHold$58.00 ➝ $60.00Low
i
12/11/2019Wells Fargo & CompanyDowngradeOverweight ➝ Equal WeightLow
i
12/9/2019Wells Fargo & CompanyReiterated RatingOutperform ➝ Market Perform$65.00 ➝ $61.00Low
i
10/30/2019Pivotal ResearchLower Price TargetHold$60.00 ➝ $55.00Low
i
10/23/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$73.00 ➝ $63.00Low
i
10/3/2019Bank of AmericaLower Price TargetUnderperform$51.00 ➝ $50.00Low
i
9/27/2019Royal Bank of CanadaDowngradeHold$59.00Medium
i
Rating by Anton Hie at Royal Bank of Canada
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageSellLow
i
9/9/2019Cleveland ResearchReiterated RatingHoldHigh
i
Rating by Rob Eich at Cleveland Research
8/23/2019Morgan StanleyLower Price TargetEqual Weight$61.00 ➝ $58.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
6/28/2019JPMorgan Chase & Co.Lower Price TargetOverweight$74.00 ➝ $73.00Low
i
6/3/2019Bank of AmericaLower Price TargetUnderperform$53.00 ➝ $51.00Medium
i
5/14/2019Morgan StanleySet Price TargetHold$61.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
4/18/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$59.00Low
i
4/3/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$67.00 ➝ $61.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
4/3/2019SunTrust BanksBoost Price TargetHold$58.00Low
i
4/3/2019CitigroupLower Price TargetNeutral ➝ Neutral$76.00 ➝ $60.00Low
i
4/3/2019UBS GroupLower Price TargetSell ➝ Sell$60.00 ➝ $49.00Low
i
4/3/2019Pivotal ResearchLower Price TargetHold$70.00 ➝ $60.00High
i
4/3/2019Wells Fargo & CompanyLower Price TargetOutperform$75.00 ➝ $65.00High
i
4/3/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $60.00High
i
4/3/2019Loop CapitalDowngradeBuy ➝ Hold$77.00 ➝ $60.00High
i
Rating by Andrew Wolf at Loop Capital
3/31/2019CowenReiterated RatingHold$66.00Low
i
3/28/2019MizuhoSet Price TargetHold$67.00Low
i
Rating by Ann Hynes at Mizuho
3/27/2019Loop CapitalLower Price TargetBuy$77.00Low
i
Rating by Andrew Wolf at Loop Capital
3/8/2019Bank of AmericaReiterated RatingUnderperform ➝ Underperform$69.00 ➝ $62.00Low
i
3/5/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$77.00 ➝ $67.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
3/4/2019UBS GroupLower Price TargetSell ➝ Sell$70.00 ➝ $65.00High
i
3/1/2019Robert W. BairdLower Price TargetNeutral ➝ Neutral$70.00 ➝ $67.00Medium
i
Rating by Eric Coldwell at Robert W. Baird
1/23/2019Loop CapitalSet Price TargetBuy$82.00Low
i
Rating by Andrew Wolf at Loop Capital
1/17/2019UBS GroupInitiated CoverageSell ➝ Sell$70.00Low
i
12/21/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$71.00 ➝ $70.00High
i
12/20/2018Needham & Company LLCUpgradeBuy$94.00Low
i
Rating by Kevin Caliendo at Needham & Company LLC
12/20/2018Loop CapitalSet Price TargetBuy$82.00High
i
Rating by Andrew Wolf at Loop Capital
12/19/2018Wolfe ResearchReiterated RatingPeer Perform ➝ Peer PerformHigh
i
12/14/2018Goldman Sachs GroupDowngradeNeutral ➝ SellHigh
i
12/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$55.00 ➝ $77.00Medium
i
10/15/2018Pivotal ResearchBoost Price TargetHold ➝ Hold$60.00 ➝ $72.00Medium
i
Rating by Ajay Jain at Pivotal Research
10/12/2018BarclaysBoost Price TargetEqual Weight$77.00 ➝ $80.00Medium
i
10/12/2018Robert W. BairdBoost Price TargetNeutral$69.00 ➝ $71.00Medium
i
10/12/2018CitigroupBoost Price TargetNeutral$69.00 ➝ $76.00Medium
i
10/12/2018SunTrust BanksBoost Price TargetHold$75.00High
i
10/12/2018Loop CapitalBoost Price TargetBuy$80.00 ➝ $82.00High
i
Rating by Andrew Wolf at Loop Capital
10/8/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$83.00 ➝ $91.00High
i
10/8/2018Royal Bank of CanadaSet Price TargetOutperform ➝ Outperform$68.00 ➝ $82.00High
i
9/11/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$64.00 ➝ $69.00Low
i
7/23/2018CowenDowngradeOutperform ➝ Market Perform$104.00Low
i
7/9/2018CitigroupDowngradeBuy ➝ Neutral$69.00Low
i
7/2/2018Pivotal ResearchLower Price TargetHold$70.00 ➝ $60.00Low
i
Rating by Ajay Jain at Pivotal Research
7/2/2018MizuhoDowngradeBuy ➝ Neutral$64.00Medium
i
Rating by Ann Hynes at Mizuho
6/29/2018Royal Bank of CanadaReiterated RatingOutperformLow
i
Rating by George Hill at Royal Bank of Canada
6/29/2018Loop CapitalBoost Price TargetBuy$80.00Low
i
Rating by Andrew Wolf at Loop Capital
6/29/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$85.00 ➝ $65.00Low
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
6/29/2018Robert W. BairdDowngradeOutperform ➝ Neutral$80.00Low
i
6/28/2018Bank of AmericaDowngradeNeutral ➝ Underperform$73.00 ➝ $60.00High
i
Rating by Michael Cherny at Bank of America Co.
5/29/2018MizuhoSet Price TargetBuy$77.00Medium
i
Rating by Ann Hynes at Mizuho
5/23/2018SVB LeerinkLower Price TargetMarket Perform ➝ Market Perform$75.00 ➝ $70.00Low
i
4/3/2018Jefferies Financial GroupSet Price TargetBuy$85.00Low
i
Rating by Brian Tanquilut at Jefferies Financial Group Inc.
4/2/2018ScotiabankLower Price TargetOutperform$93.00 ➝ $91.00Low
i
3/29/2018Pivotal ResearchSet Price TargetHold$70.00Low
i
Rating by Ajay Jain at Pivotal Research
3/28/2018Royal Bank of CanadaSet Price TargetBuy$88.00High
i
Rating by George Hill at Royal Bank of Canada
3/23/2018Pivotal ResearchLower Price TargetHold$73.00 ➝ $69.00High
i
Rating by Ajay Jain at Pivotal Research
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$76.00Low
i
2/27/2018Bank of AmericaInitiated CoverageNeutral ➝ Neutral$76.00High
i
2/16/2018Royal Bank of CanadaSet Price TargetBuy$94.00Low
i
2/13/2018Loop CapitalSet Price TargetBuy$90.00Medium
i
Rating by Andrew Wolf at Loop Capital
1/24/2018MizuhoSet Price TargetBuy$87.00Low
i
Rating by Ann Hynes at Mizuho
1/10/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$86.00 ➝ $88.00Low
i
1/5/2018Pivotal ResearchSet Price TargetHold$73.00High
i
Rating by Ajay Jain at Pivotal Research
1/4/2018Robert W. BairdReiterated RatingBuy$82.00Medium
i
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$80.00High
i
1/3/2018Loop CapitalSet Price TargetBuy$90.00High
i
Rating by Andrew Wolf at Loop Capital
12/21/2017SunTrust BanksSet Price TargetHold$80.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
12/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$78.00Low
i
11/22/2017Needham & Company LLCLower Price TargetBuy$86.00N/A
i
11/2/2017CitigroupLower Price TargetBuy$95.00 ➝ $81.00N/A
i
11/1/2017SVB LeerinkDowngradeOutperform ➝ Market PerformN/A
i
Rating by D. Larsen at SVB Leerink LLC
10/29/2017Jefferies Financial GroupSet Price TargetBuy$93.00N/A
i
10/26/2017Loop CapitalSet Price TargetBuy$95.00 ➝ $90.00N/A
i
10/25/2017Royal Bank of CanadaReiterated RatingBuy$88.00N/A
i
10/24/2017MizuhoSet Price TargetBuy$94.00N/A
i
10/24/2017Pivotal ResearchLower Price TargetHold ➝ Hold$85.00 ➝ $73.00N/A
i
10/19/2017Robert W. BairdReiterated RatingOutperform$90.00 ➝ $80.00N/A
i
10/15/2017SunTrust BanksSet Price TargetHold$72.00N/A
i
10/12/2017Needham & Company LLCReiterated RatingBuy$94.00N/A
i
10/6/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$95.00 ➝ $85.00N/A
i
10/2/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
i
9/27/2017Raymond JamesReiterated RatingOutperform ➝ Market PerformLow
i
9/20/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
i
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$96.00Medium
i
9/16/2017Needham & Company LLCReiterated RatingBuy$94.00Low
i
9/10/2017Needham & Company LLCReiterated RatingBuy$94.00Low
i
9/7/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
i
8/24/2017Loop CapitalInitiated CoverageBuy ➝ Buy$95.00Low
i
8/23/2017UBS GroupReiterated RatingBuy$97.00 ➝ $96.00Low
i
7/17/2017Needham & Company LLCSet Price TargetBuy$94.00Low
i
7/13/2017Credit Suisse GroupReiterated RatingBuy$97.00Low
i
7/7/2017SVB LeerinkSet Price TargetBuy$90.00 ➝ $86.00Low
i
7/3/2017CitigroupReiterated RatingBuyLow
i
7/3/2017GuggenheimReiterated RatingBuyLow
i
7/3/2017Morgan StanleyReiterated RatingOverweight$95.00Low
i
7/2/2017Pivotal ResearchSet Price TargetHold$85.00Low
i
6/30/2017Needham & Company LLCUpgradeHold ➝ Buy$94.00Low
i
6/28/2017Goldman Sachs GroupReiterated RatingNeutral$89.00 ➝ $77.00Low
i
6/27/2017Needham & Company LLCInitiated CoverageHold ➝ HoldLow
i
5/31/2017Jefferies Financial GroupLower Price TargetBuy$95.00 ➝ $80.00Medium
i
4/11/2017SVB LeerinkSet Price TargetBuy$90.00Low
i
4/6/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
i
4/6/2017GuggenheimReiterated RatingBuy$100.00Low
i
4/4/2017Pivotal ResearchInitiated CoverageHold ➝ Hold$85.00Medium
i
4/1/2017BarclaysSet Price TargetHold$79.00Low
i
3/31/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
i
3/27/2017Robert W. BairdReiterated RatingOutperform$96.00Low
i
3/22/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$92.00Low
i
2/6/2017Atlantic SecuritiesUpgradeNeutral ➝ Overweight$95.00N/A
i
1/31/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$92.00N/A
i
1/31/2017Evercore ISIReiterated RatingBuy$93.00N/A
i
1/31/2017Wells Fargo & CompanyReiterated RatingOutperformN/A
i
1/24/2017Robert W. BairdReiterated RatingOutperformN/A
i
1/23/2017Jefferies Financial GroupReiterated RatingBuy$95.00N/A
i
1/21/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$92.00N/A
i
1/8/2017SVB LeerinkSet Price TargetBuy$90.00N/A
i
1/6/2017Deutsche Bank AktiengesellschaftReiterated RatingBuy$88.00N/A
i
1/6/2017Jefferies Financial GroupReiterated RatingBuy$95.00N/A
i
12/21/2016Jefferies Financial GroupReiterated RatingBuyN/A
i
11/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$88.00N/A
i
11/8/2016SVB LeerinkSet Price TargetBuy$90.00N/A
i
11/8/2016Jefferies Financial GroupSet Price TargetBuy$95.00N/A
i
10/31/2016Wells Fargo & CompanyInitiated CoverageOutperformN/A
i
10/23/2016Jefferies Financial GroupSet Price TargetBuy$95.00N/A
i
10/21/2016BarclaysSet Price TargetHold$79.00N/A
i
10/21/2016Credit Suisse GroupReiterated RatingOutperform$95.00N/A
i
10/20/2016Deutsche Bank AktiengesellschaftLower Price TargetBuy$94.00 ➝ $88.00N/A
i
10/17/2016Jefferies Financial GroupUpgradeHold ➝ Buy$87.00 ➝ $95.00N/A
i
10/5/2016UBS GroupInitiated CoverageBuy$80.51 ➝ $94.00N/A
i
10/4/2016Robert W. BairdReiterated RatingOutperform$95.00N/A
i
10/3/2016Credit Suisse GroupReiterated RatingBuy$95.00N/A
i
9/28/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$94.00N/A
i
9/19/2016SVB LeerinkReiterated RatingOutperform$95.00N/A
i
9/10/2016Robert W. BairdReiterated RatingOutperform$95.00N/A
i
9/9/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$94.00N/A
i
9/1/2016Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$80.71 ➝ $95.00N/A
i
8/30/2016Bank of AmericaReiterated RatingBuy$94.00N/A
i
8/30/2016Deutsche Bank AktiengesellschaftBoost Price TargetBuy$93.00 ➝ $94.00N/A
i
8/30/2016SVB LeerinkReiterated RatingOutperformN/A
i
7/22/2016Keefe, Bruyette & WoodsReiterated RatingMarket Perform ➝ UnderperformN/A
i
7/18/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
7/18/2016Credit Suisse GroupReiterated RatingBuy$95.00 ➝ $82.51N/A
i
7/7/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
7/7/2016BarclaysBoost Price TargetEqual Weight$76.00 ➝ $79.00N/A
i
7/7/2016Jefferies Financial GroupReiterated RatingHold ➝ NeutralN/A
i
7/7/2016FBR & CoLower Price TargetMarket Perform$90.00 ➝ $85.00N/A
i
7/7/2016Evercore ISIReiterated RatingBuy$93.00N/A
i
6/27/2016Robert W. BairdReiterated RatingOutperform$98.00N/A
i
6/13/2016Bank of AmericaReiterated RatingBuyN/A
i
6/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
6/7/2016Bank of AmericaReiterated RatingBuy$94.00 ➝ $78.66N/A
i
4/19/2016Jefferies Financial GroupReiterated RatingHoldN/A
i
4/11/2016SVB LeerinkReiterated RatingBuy$95.00N/A
i
4/7/2016Credit Suisse GroupReiterated RatingBuy$95.00N/A
i
4/6/2016Evercore ISIReiterated RatingBuy$95.00N/A
i
4/5/2016Evercore ISIBoost Price TargetBuy$94.00 ➝ $95.00N/A
i
4/2/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
4/1/2016Morgan StanleyReiterated RatingBuy$95.00N/A
i
3/19/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$95.00N/A
i
3/16/2016Credit Suisse GroupInitiated CoverageOutperform RatingsN/A
i
3/15/2016Credit Suisse GroupReiterated RatingOutperform$100.00 ➝ $92.00N/A
i
3/10/2016BarclaysLower Price TargetEqual Weight$81.00 ➝ $76.00N/A
i
3/1/2016MizuhoUpgradeNeutral ➝ Buy$89.00 ➝ $90.00N/A
i
2/12/2016FBR & CoReiterated RatingMarket PerformN/A
i
2/10/2016Deutsche Bank AktiengesellschaftReiterated RatingBuyN/A
i
2/6/2016CitigroupReiterated RatingBuy$111.00 ➝ $88.00N/A
i
1/21/2016Robert W. BairdInitiated CoverageOutperform$96.00N/A
i
1/10/2016FBR & CoReiterated RatingMarket Perform$90.00N/A
i
1/8/2016GuggenheimReiterated RatingBuyN/A
i
1/8/2016SVB LeerinkReiterated RatingBuy$105.00N/A
i
1/6/2016Deutsche Bank AktiengesellschaftReiterated RatingBuy$95.00N/A
i
1/6/2016Evercore ISIUpgradeHold ➝ Buy$94.50N/A
i
12/15/2015Jefferies Financial GroupReiterated RatingHold$95.00 ➝ $90.00N/A
i
11/16/2015SVB LeerinkReiterated RatingBuyN/A
i
11/16/2015Raymond JamesUpgradeMarket Perform ➝ OutperformN/A
i
11/16/2015Credit Suisse GroupLower Price TargetOutperform$110.00 ➝ $100.00N/A
i
10/30/2015ScotiabankBoost Price Target$100.00 ➝ $101.00N/A
i
10/29/2015S&P Equity ResearchReiterated RatingBuy$99.00N/A
i
10/29/2015BarclaysLower Price TargetEqual Weight$86.00 ➝ $81.00N/A
i
10/28/2015CowenReiterated RatingBuy$102.00N/A
i
10/28/2015Royal Bank of CanadaUpgradeHold ➝ Buy$98.00 ➝ $103.00N/A
i
10/28/2015Jefferies Financial GroupBoost Price TargetHold$90.00 ➝ $105.00N/A
i
(Data available from 10/23/2015 forward)
Walgreens Boots Alliance logo
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics. It also provides specialty pharmacy services and mail services; and manages in-store clinics. As of August 31, 2018, this segment operated 9,560 retail stores under the Walgreens and Duane Reade brands in the United States; and 7 specialty pharmacies, as well as approximately 400 in-store clinic locations. The Retail Pharmacy International segment sells prescription drugs; and health, beauty, personal care, and other consumer products through its pharmacy-led health and beauty stores and optical practices, as well as through boots.com and an integrated mobile application. This segment operated 4,767 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 618 optical practices, including 167 on a franchise basis. The Pharmaceutical Wholesale segment engages in the wholesale and distribution of specialty and generic pharmaceuticals, health and beauty products, and home healthcare supplies and equipment, as well as provides related services to pharmacies and other healthcare providers. This segment operates in the United Kingdom, Germany, France, Turkey, Spain, the Netherlands, Egypt, Norway, Romania, the Czech Republic, and Lithuania. The company has a strategic partnership with Microsoft Corporation. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Read More

Today's Range

Now: $38.04
$37.57
$38.08

50 Day Range

MA: $36.27
$34.67
$37.64

52 Week Range

Now: $38.04
$33.88
$64.50

Volume

3,667,125 shs

Average Volume

6,579,447 shs

Market Capitalization

$32.94 billion

P/E Ratio

76.08

Dividend Yield

5.06%

Beta

0.44